CVS Caremark backs Zepbound


▪ CVS Caremark backs Zepbound — access expands, but pricing likely bends.

Read More: https://bit.ly/LLY-NVO

#HealthcareInvesting #GLP1 #Equities #Pharma #GrowthVsValue #EliLilly #NovoNordisk #Biotech #PortfolioStrategy #Markets

Leave a comment